Fabian Benencia

Molecular and Cell Biology Program, Ohio University

Affiliated withOhio University College of Osteopathic Medicine, Ohio University Russ College of Engineering and Technology, Ohio University

Research Area

Immunology and Infection

Biography

Fabian Benencia has not added Biography.
If you are Fabian Benencia and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 28	2011

Other Publications

Article	Year
Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. Biochemical and biophysical research communications\| PubMed ID: 11944893	2002
Effect of undernourishment on Herpes Simplex Virus Type 1 ocular infection in the Wistar rat model. International journal of experimental pathology\| PubMed ID: 12084042	2002
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. The American journal of pathology\| PubMed ID: 12466143	2002
Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm. Current gene therapy\| PubMed ID: 12653405	2003
Nitric oxide and HSV vaginal infection in BALB/c mice. Virology\| PubMed ID: 12726728	2003
Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer biology & therapy\| PubMed ID: 14508119	2003
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. Cancer research\| PubMed ID: 15026360	2004
Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route. Immunology letters\| PubMed ID: 15081619	2004
Early inhibition of nitric oxide production increases HSV-1 intranasal infection. Journal of medical virology\| PubMed ID: 15122810	2004
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nature medicine\| PubMed ID: 15334073	2004
Vascular leukocytes contribute to tumor vascularization. Blood\| PubMed ID: 15358628	2005
Expression of IL-15, IL-18 and NOS-II in contralateral eyes of BALB/c mice during the development of HSV-induced keratitis. Immunology letters\| PubMed ID: 15585336	2005
HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 15925544	2005
Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma. Human gene therapy\| PubMed ID: 15960607	2005
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer biology & therapy\| PubMed ID: 16627987	2006
Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity. Cancer biology & therapy\| PubMed ID: 16861891	2006
Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer. Advances in experimental medicine and biology\| PubMed ID: 17191386	2007
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature medicine\| PubMed ID: 18157142	2008
Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. Journal of translational medicine\| PubMed ID: 18445282	2008
Wnt5a is expressed in murine and human atherosclerotic lesions. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 18456733	2008
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation. Cancer biology & therapy\| PubMed ID: 18458533	2008
Biological therapy with oncolytic herpesvirus. Advances in experimental medicine and biology\| PubMed ID: 18546631	2008
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer research\| PubMed ID: 18768667	2008
Modulation of the antitumor immune response by complement. Nature immunology\| PubMed ID: 18820683	2008
In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging\| PubMed ID: 19194761	2009
Aminoguanidine administered during the induction of oral tolerance alters the systemic response of the tolerised rats. Cellular immunology\| PubMed ID: 19931043	2010
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of translational medicine\| PubMed ID: 20003308	2009
Whole tumor antigen vaccines. Seminars in immunology\| PubMed ID: 20356763	2010
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of translational medicine\| PubMed ID: 21609494	2011
The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. BMC immunology\| PubMed ID: 21645356	2011